Join the club for FREE to access the whole archive and other member benefits.

Genomics is opening new frontiers for precision medicine

03-Oct-2016

Key points from article :

A decade after the Human Genome Project was declared complete the cost to sequence DNA has plummeted roughly a millionfold.

Even more improvements expected over the next five to ten years.

Genetic testing is becoming more common as part of some patient treatment plans.

Doctors practice precision oncology to obtain genome sequences of both the tumour and the individual.

Genomics has been applied to studying diseases spanning from depression to diabetes to high cholesterol.

Mentioned in this article:

Click on resource name for more details.

Eric Green

Director of the National Human Genome Research Institute (NHGRI) at NIH.

Intermountain Healthcare

Not-for-profit healthcare system and largest healthcare provider in the Intermountain West of the US.

James Zwiebel

Former Chief, Investigational Drug Branch at NCI Cancer Therapy Evaluation Program.

Joel Diamond

Chief Medical Officer at 2bPrecise LLC, Genomics & Precision Medicine

Michael Hultner

VP, Head of Genomics Strategy at Optum.

National Cancer Institute (NCI)

Institute for cancer research.

Pravin J. Mishra

Director of Research and Development Center at Intermountain Healthcare.

Topics mentioned on this page:
Precision Medicine